glp 1 approved for heart disease Can GLP-1 Drugs protection in Autoimmune Disease? The FDA has approved a

dose-dependent response across 3, 6, and 9 mg arms Phase 3 T2D : HbA1c reductions up to 2.15% versus placebo in Chinese population trials Phase 1b/2 data : Earlier dose-finding studies establishing the efficacy and tolerability profile Global development : Ongoing clinical trials outside China, but no FDA approval or submission as of early 2026 Limitation : Primary clinical data from Chinese population

Weve all seen the headlines about GLP-1 drugs, said CU Anschutz Chancellor Don Elliman, kicking off the program during the 2026 Transforming Healthcare lecture series on April 28

Molecules (2023) 28(2):887

However, although currently there are no comparing studies on the efficacy of different doses of liraglutide in improving body composition, it is tempting to speculate that greater changes in body composition might be expected through administration of higher doses of liraglutide